MADISON HEALTH

Madison Diseases News

Across Madison, coverage here takes in disease news from diagnosis and treatment to public health impact. Reporting follows outbreak alerts, treatment approvals, clinical trials and the research that shapes how conditions are understood.

Crowley Gets Flu, COVID Shots Amid Measles Rise

Crowley Gets Flu, COVID Shots Amid Measles Rise

Governor-elect David Crowley received flu and COVID-19 vaccinations at UW Health in Madison as a second child dies from measles in Wisconsin.

Live Poll

Do you plan to get your flu or COVID-19 vaccination this season?


Cancer

Cancer

UW-Health Offers GammaTile Brain Tumor Treatment

The radiation-releasing tiles are placed in the surgical site after tumor removal to target cells that may remain.

UW-Health Offers GammaTile Brain Tumor Treatment

Stroke

Live Poll

In your area, do you trust that medical facilities are adequately prepared to treat swallowing disorders?

Stroke

Researcher Addressed Dysphagia Treatment Gaps

Nicole Rogus-Pulia presented new precision public health strategies for swallowing disorders in Madison.

Researcher Addressed Dysphagia Treatment Gaps

Autism

Live Poll

Do you trust local doctors' offices to accommodate children with sensory needs?

Autism

Madison Clinic Offers Sensory-Friendly Vaccines

The fourth annual clinic at Madison Children's Museum serves children with autism and sensory sensitivities.

Madison Clinic Offers Sensory-Friendly Vaccines

Asthma

Live Poll

Do you plan to get a flu or respiratory vaccine before the holidays?

Asthma

UW Health Urges Flu Shots Before Holidays

Respiratory illnesses have begun across Wisconsin and northern Illinois, and UW Health is encouraging vaccination before holiday gatherings.

UW Health Urges Flu Shots Before Holidays

More in Diseases

Reporting here centers on new treatments for specific conditions, outbreak alerts, studies of disease risk factors and results from clinical trials. Coverage runs across the city and into the communities around it wherever a condition touches local patients or local research. Outbreak alerts and trial results tend to draw the most attention, though the slower-moving stories on risk factors often shape public understanding more. Access to newly approved treatments and the cost of care are the constraints that most often decide whether a breakthrough reaches the people it was designed for.